New Young Institute Advisory Council to bolster Purdue pharmaceutical manufacturing mission

WEST LAFAYETTE, Ind. — The William D. and Sherry L. Young Advanced Manufacturing of Pharmaceuticals Institute at Purdue University announced Wednesday (March 6) the appointment of a new advisory council that will provide strategic guidance to support the institute’s efforts to innovate and advance pharmaceutical manufacturing. 

The council’s five members bring expertise, business acumen, regulatory perspectives and technical skills to the institute’s mission to improve pharmaceutical manufacturing through research and workforce training. The Young Institute was established in 2022 as part of a $250 million investment in the life sciences at Purdue — a priority within the Purdue Moves initiatives, the university’s strategic plan.

The new advisors are: Robert A. Baffi; Mitchell E. Daniels, Jr.; Michael A. Klobuchar; Moheb M. Nasr; and William D. Young.

More information is available on the Purdue Office of Research website.

Media are welcome to share, post and publish these stories, photos and videos.

Media contact: Amy Raley, araley@purdue.edu 

About Purdue University 

Purdue University is a public research institution demonstrating excellence at scale. Ranked among top 10 public universities and with two colleges in the top four in the United States, Purdue discovers and disseminates knowledge with a quality and at a scale second to none. More than 105,000 students study at Purdue across modalities and locations, including nearly 50,000 in person on the West Lafayette campus. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition 13 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its first comprehensive urban campus in Indianapolis, the new Mitchell E. Daniels, Jr. School of Business, and Purdue Computes — at https://www.purdue.edu/president/strategic-initiatives.